128940.KS

Potentially Undervalued

Hanmi Pharm. Co., Ltd. — PEG Ratio Analysis

0.56

PEG Ratio

0.56

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$491000.00

TTM EPS

$15005.17

P/E Ratio

32.72

Growth Rate

58.0%

5-Year EPS CAGR

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Calculated

6/17/2026

9:16:28 AM

Peer Comparison

Sample Size

4 peers

Industry Median PEG

3.39

25th Percentile

0.41

75th Percentile

80.02

128940.KS PEG (0.56) vs Industry Median (3.39): 83% discount

Symbol	Company	PEG	P/E	Growth	vs 128940.KS
069620.KS	Daewoong pharmaceutical Co.,Ltd	0.15	7.5	49.7%	-73%
008930.KS	Hanmi Science Co., Ltd.	0.41	16.1	39.6%	-28%
068270.KS	Celltrion, Inc.	6.38	28.9	4.5%	+1031%
000100.KS	Yuhan Corporation	80.02	33.6	0.4%	+14084%

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.